| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Medical Officer | VP Of Drug Development
2 companies
Pratt Raymond Dennis is a VP Of Drug Development at ROCKWELL MEDICAL, INC. with holdings across 2 companies. Recent SEC Form 4 filings include 4 buys and 0 sells.
Estimated insider holdings value: $2.1M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 26, 2023 | SVRA Savara Inc | Chief Medical Officer | Buy | 6,500 | $2.93 | $19,045.00 | +4.2% | +41.1% | +43.4% | |
| Dec 22, 2022 | SVRA Savara Inc | Chief Medical Officer | Buy | 3,500 | $1.54 | $5,401.90 | +2.3% | +30.8% | +235.6% | |
| Aug 13, 2015 | RMTI Rockwell Medical, Inc. | VP Of Drug Development | Buy | 5,000 | $11.54 | $57,675.44 | +1.6% | - | - |